FINWIRES · TerminalLIVE
FINWIRES

BMO Capital Initiates LB Pharmaceuticals at Outperform With $46 Price Target

By

LB Pharmaceuticals, Inc. (LBRX) has an average rating of buy and mean price target of $45.11, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles